ALKS vs KEY
Alkermes Plc (ALKS) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the ALKS and KEY stock pages for the full models.
Not investment advice.